From: Earlobe arterialized capillary blood gas analysis in the intensive care unit: a pilot study
Patients | 55 |
---|---|
Male | 40 (72.7%) |
Age in years | 63 (24 to 83) |
Arterial hypertension | 23 (41.8%) |
Diabetes mellitus | 19 (34.5%) |
Chronic cardiac failure | 4 (7.3%) |
Severe vasculopathy | 4 (7.3%) |
Renal insufficiency | 5 (9.1%) |
Diagnostic at ICU admission | |
Severe sepsisa | 21 (38.1%) |
Respiratory failure | 7 (12.7%) |
Severe trauma | 7 (12.7%) |
Neurological | 6 (10.8%) |
Cardiogenic shock | 5 (9.1%) |
Miscellaneous | 9 (16%) |
Clinical variables | |
PEEP (cmH2O) | 7.1 (4 to 12) |
FiO2 | 0.36 (0.21 to 0.66) |
Minute volume (L/min) | 9 (5.5 to 19) |
APACHE II | 18.3 (3 to 34) |
Mean arterial pressure (mmHg) | 80 (57 to 113) |
Cardiac index (L/min/m2) | 3.2 (1 to 5.9) |
Arterial lactate (mg/dl) | 18.7 (6 to 71) |
Arterial lactate > 22 mg/dl | 10 (18%) |
Sepsisa | 32 (58.2%) |
Platelets (× 103/dl) | 226 (54 to 669) |
Prothrombin time (ratio) | 1.2 (1 to 1.9) |
Prophylactic anticoagulant | 40 (72.7%) |
Antiplatelet treatment | 6 (10.9%) |
Vasoactive treatment | 36 (65.5%) |
NE | 30 (83.3%) |
NE dose (μg/kg/min) | 0.49 (0.02 to 3.02) |
Other vasoconstriction treatment | 3 (8.2%) |
Inotropic treatment | 5 (13.8%) |
Vasodilation treatment | 2 (5.5%) |